These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 8518699)
1. Hepatitis C from immunoglobin infusions. Lehner PS; Webster AD BMJ; 1993 Jun; 306(6891):1541-2. PubMed ID: 8518699 [No Abstract] [Full Text] [Related]
2. Hepatitis C and immune globulin. Prince AM; Horowitz B N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325 [No Abstract] [Full Text] [Related]
3. Hepatitis C and immune globulin. Douglas SD; Slade HB N Engl J Med; 1995 May; 332(18):1235; author reply 1236-7. PubMed ID: 7700323 [No Abstract] [Full Text] [Related]
4. Transmission of viral infections through intravenous immune globulin. Schiff RI N Engl J Med; 1994 Dec; 331(24):1649-50. PubMed ID: 7969346 [No Abstract] [Full Text] [Related]
5. Follow-up studies of hepatitis C association with an intravenous immunoglobulin. Yu MW Dev Biol Stand; 1996; 88():215-6. PubMed ID: 9119139 [No Abstract] [Full Text] [Related]
6. Hepatitis C and immune globulin. López-Jiménez J; Odriozola J; Pérez-Oteyza J; García-Laraña J N Engl J Med; 1995 May; 332(18):1235-6. PubMed ID: 7700324 [No Abstract] [Full Text] [Related]
7. Hepatitis C virus transmission by intravenous immunoglobulin. Farrugia A; Walker E Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718 [No Abstract] [Full Text] [Related]
8. Hepatitis C virus transmission by intravenous immunoglobulin. James RC; Mosley JW Lancet; 1995 Aug; 346(8971):374; author reply 374-5. PubMed ID: 7542719 [No Abstract] [Full Text] [Related]
9. Long-term surveillance of HIV, HBV, and HCV infected patients. Shapiro A Ann Hematol; 1994; 68 Suppl 3():S87-8. PubMed ID: 8180264 [No Abstract] [Full Text] [Related]
10. Hepatitis C virus RNA in tetanus intramuscular immune globulin. Pisani G; Cristiano K; Wirz M; Pini C; Gentili G Transfusion; 1997 Sep; 37(9):986-7. PubMed ID: 9308652 [No Abstract] [Full Text] [Related]
11. Transmission of hepatitis after the administration of intravenous immunoglobulins. Rousell RH; Dobkin MB; Budinger MD; Louie RE Am J Clin Pathol; 1993 May; 99(5):649. PubMed ID: 8493958 [No Abstract] [Full Text] [Related]
15. The safety of immune globulins. Tepper M; Gully P Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937 [No Abstract] [Full Text] [Related]
16. [Hepatitis C following administration of intravenous immunoglobulins]. Cabrera Chaves T; Simón Marco MA; Gomollón García F; Botella Esteban MT; Uribarrena Echebarría R Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418 [TBL] [Abstract][Full Text] [Related]
17. Possible transmission of hepatitis C virus infection with intravenous immunoglobulin. Schiano TD; Bellary SV; Black M Ann Intern Med; 1995 May; 122(10):802-3. PubMed ID: 7717610 [No Abstract] [Full Text] [Related]
18. 111 cases of hepatitis C linked to Gammagard. Patient screening recommended. Am J Hosp Pharm; 1994 Oct; 51(19):2326. PubMed ID: 7847397 [No Abstract] [Full Text] [Related]
19. HCV and Gammagard in France. Gomperts ED Lancet; 1994 Jul; 344(8916):201. PubMed ID: 7912801 [No Abstract] [Full Text] [Related]